Diabetes Care, Vol 23, Issue 12 1799-1803, Copyright © 2000 by American Diabetes Association

ARTICLES

Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes

JC Cappelleri, RA Gerber, IA Kourides and RA Gelfand
Pfizer Inc., Global Research and Development, Groton, Connecticut 06340, USA. joseph_c_cappelleri@groton.pfizer.com

OBJECTIVE: To develop a self-administered questionnaire to address alternative delivery routes of insulin and to investigate aspects of patient satisfaction that may be useful for subsequent assessment and comparison of an inhaled insulin regimen and a subcutaneous insulin regimen. RESEARCH DESIGN AND METHODS: Attributes of patient treatment satisfaction with both inhaled and injected insulin therapy were derived from five qualitative research studies to arrive at a 15-item questionnaire. Each item was analyzed on a five-point Likert scale so that higher item scores indicated a more favorable attitude. There were 69 subjects with type 1 diabetes previously taking injected insulin therapy who were enrolled in a phase II clinical trial. Their baseline responses on the questionnaire were evaluated and subjected to an exploratory factor analysis. Meaningful factors were retained and interpreted based on their psychometric properties. RESULTS: Exploratory factor analysis suggested a two-factor solution accounting for 66 and 20% of the variance, respectively. The first factor contained 10 reliable items (Cronbach's alpha = 0.89) relating to convenience and ease of use, and the second contained 5 reliable items (Cronbach's alpha = 0.82) relating to social comfort. CONCLUSIONS: Among patients with type 1 diabetes, this analysis highlighted and quantified two key factors contributing to patient satisfaction: convenience/ease of use and social comfort. The questionnaire underwent rigorous development, had reliable properties, and an interpretable and rich factor structure. This report is intended to help advance, in subsequent investigations, the understanding and measurement of treatment satisfaction with novel and existing forms of insulin delivery.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. M. Davis, C. M. Christensen, K. K. Nystrom, P. A. Foral, and C. Destache Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization Am. J. Health Syst. Pharm., July 15, 2008; 65(14): 1347 - 1357. [Abstract] [Full Text] [PDF]

				F. Petrak, E. Stridde, F. Leverkus, A. A. Crispin, T. Forst, and A. Pfutzner Development and Validation of a New Measure to Evaluate Psychological Resistance to Insulin Treatment Diabetes Care, September 1, 2007; 30(9): 2199 - 2204. [Abstract] [Full Text] [PDF]

				S. Ghosh and A. Collier Inhaled insulins Postgrad. Med. J., March 1, 2007; 83(977): 178 - 181. [Abstract] [Full Text] [PDF]

				T. Quattrin, A. Belanger, N. J.V. Bohannon, S. L. Schwartz, and for the Exubera Phase III Study Group Efficacy and Safety of Inhaled Insulin (Exubera) Compared With Subcutaneous Insulin Therapy in Patients With Type 1 Diabetes: Results of a 6-month, randomized, comparative trial Diabetes Care, November 1, 2004; 27(11): 2622 - 2627. [Abstract] [Full Text] [PDF]

				J. Rosenstock, J. C. Cappelleri, B. Bolinder, and R. A. Gerber Patient Satisfaction and Glycemic Control After 1 Year With Inhaled Insulin (Exubera) in Patients With Type 1 or Type 2 Diabetes Diabetes Care, June 1, 2004; 27(6): 1318 - 1323. [Abstract] [Full Text] [PDF]

				S. A Amiel and K G. M M Alberti Inhaled insulin BMJ, May 22, 2004; 328(7450): 1215 - 1216. [Full Text] [PDF]

				R. A. Gerber, J. C. Cappelleri, I. A. Kourides, and R. A. Gelfand Treatment Satisfaction With Inhaled Insulin in Patients With Type 1 Diabetes: A randomized controlled trial Diabetes Care, September 1, 2001; 24(9): 1556 - 1559. [Abstract] [Full Text] [PDF]